THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 122 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,961,599 | +78458.2% | 227,300 | -1.2% | 0.08% | -12.0% |
Q1 2023 | $2,497 | +19.5% | 230,100 | +23.5% | 0.09% | +58.6% |
Q4 2022 | $2,090 | -99.9% | 186,300 | -17.2% | 0.06% | +81.2% |
Q3 2022 | $2,282,000 | -73.3% | 225,000 | -61.7% | 0.03% | -86.5% |
Q2 2021 | $8,533,000 | +3272.7% | 587,666 | +7841.4% | 0.24% | +5825.0% |
Q3 2017 | $253,000 | -57.1% | 7,400 | -79.4% | 0.00% | -20.0% |
Q4 2015 | $590,000 | +44.3% | 35,952 | +52.5% | 0.01% | -16.7% |
Q1 2015 | $409,000 | -52.6% | 23,568 | -59.2% | 0.01% | -45.5% |
Q4 2014 | $862,000 | – | 57,773 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 11,213,879 | $254,331,000 | 30.84% |
Cormorant Asset Management, LP | 1,300,000 | $29,484,000 | 2.18% |
Baupost Group | 9,309,168 | $211,132,000 | 1.85% |
SENZAR ASSET MANAGEMENT, LLC | 27,397 | $621,000 | 1.79% |
ARMISTICE CAPITAL, LLC | 1,180,000 | $26,762,000 | 1.75% |
Old West Investment Management, LLC | 111,101 | $2,519,000 | 1.27% |
Chescapmanager LLC | 403,321 | $9,147,000 | 1.06% |
Virtus ETF Advisers LLC | 30,055 | $682,000 | 0.60% |
Rock Springs Capital Management LP | 652,600 | $14,801,000 | 0.57% |
Foundation Asset Management, LP | 27,154 | $616,000 | 0.53% |